Acute and Late Toxicity after Three-Dimensional Conformal Image-Guided Radiotherapy for Localized Prostate Cancer

REFERENCES

• Jemal A, Siegel R, Ward E, Cancer Statistics, 2009. CA Cancer J Clin. 2009;59(4):225–249.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Autier P, Boniol M, Estimates of cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18(3):581–592.
   PubMed Web of Science ®Google Scholar
• Peschel RE, Colberg JW. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 2003;4(4):233–241.
   PubMed Web of Science ®Google Scholar
• D'Amico AV, Whittington R, Kaplan I, Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4–20 ng/ml. Int J Radiat Oncol Biol Phys 1997. 37(5):1053–1058.
   PubMed Web of Science ®Google Scholar
• D'Amico AV, Whittington R, Malkowicz SB, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280(11):969–974.
   PubMed Web of Science ®Google Scholar
• Potters L, Klein EA, Kattan MW, Monotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004;71(1):29–33.
   PubMed Web of Science ®Google Scholar
• Aizer AA, Yu JB, Colberg JW, Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol 2009;93(2):185–191.
   PubMed Web of Science ®Google Scholar
• Welz S, Nyazi M, Belka C, Surgery vs. radiotherapy in localized prostate cancer. Which is best? Radiat Oncol 2008;7;3:23.
   Google Scholar
• Zelefsky MJ, Fuks Z, Hunt M, High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53(5):1111–1116.
   PubMed Web of Science ®Google Scholar
• LoSasso T, Chui CS, Kutcher GJ, The use of multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. Int J Radiat Oncol Biol Phys 1993;25(2):161–170.
   PubMed Web of Science ®Google Scholar
• Deng J, Pawlicki T, Chen Y, The MLC tongue and groove effect on IMRT dose distributions. Phys Med Biol 2001;46(4):1039–1060.
   PubMed Web of Science ®Google Scholar
• Nill S, Tucking T, Munter MW, Intensity modulated radiation therapy with multileaf collimators of different leaf widths: a comparison of achievable dose distributions. Radiother Oncol 2005;75(1):106–111.
   PubMed Web of Science ®Google Scholar
• Gong Y, Wang S, Zhou L, Dosimetric comparison using different multileaf collimeters in intensity-modulated radiotherapy for upper thoracic esophageal cancer. Radiat Oncol 2010;5:65.
   PubMedGoogle Scholar
• Abe E, Mizowaky T, Norihisa Y, Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer. J Appl Clin Med Phys 2010;11(4):3193.
   PubMed Web of Science ®Google Scholar
• Yoganathan SA, Mani KR, Das KJ,et al. Dosimetric effect of multileaf collimator leaf width in intensity-modulated radiotherapy delivery techniques for small-and large-volumes targets. J Med Phys 2011;36(2):72–77.
   PubMedGoogle Scholar
• Kubo HD, Wilder RB, Pappas CT. Impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans. Int J Radiat Oncol Biol Phys 1999;44(4):937–945.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ1, Kollmeier M, Cox B, Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2012;84(1):125–129.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Ok S, Polat B, Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol 2010;186(10):535–543.
   PubMed Web of Science ®Google Scholar
• Roach M, 3rd, Hanks G, Thames H Jr, Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65(4):965–974.
   PubMed Web of Science ®Google Scholar
• Michalsky JM, Gay H, Jackson A, Radiation dose volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S123–S129.
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Yorke ED, Marks LB, Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 2010. 76(3 Suppl):S116–S122.
   PubMed Web of Science ®Google Scholar
• Martin JM, Bayley A, Bristow R, Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol 2009;3(4):50.
   Google Scholar
• Lips IM, Dehnad H, van Gils CH, High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients. Radiat Oncol 2008;21;3:15.
   Google Scholar
• Marchand V, Bourdin S, Charbonnel C, No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study. Int J Radiat Oncol Biol Phys 2010;77(4):1053–1059.
   PubMed Web of Science ®Google Scholar
• Ghadjar P, Vock J, Vetterli D, Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking. Radiat Oncol 2008;20(3):35.
   Google Scholar
• Jackson A, Skwarchuk M, Zelefsky M, Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 2001;49(3):685–698.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Cozzarini C, Vavassori V, Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 2002;64(1):1–12.
   PubMed Web of Science ®Google Scholar
• Wachter S, Gerstner N, Goldner G, Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother Oncol 2001;59(1):65–70.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Sanguineti G, Cozzarini C, Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 2003;57(4):953–962.
   PubMed Web of Science ®Google Scholar
• Skwarchuk MW, Jackson A, Zelefsky MJ, Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000;47(1):103–113.
   PubMed Web of Science ®Google Scholar
• Heemsbergen WD, Hoogeman MS, Hart GA, Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;61(4):1011–1018.
   PubMed Web of Science ®Google Scholar
• Peeters ST, Lebesque JV, Heemsbergen WD, Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2006;64(4):1151–1161.
   PubMed Web of Science ®Google Scholar
• Munbodh R1, Jackson A, Bauer J, Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer. Med Phys 2008;35(5):2137–2150.
   PubMed Web of Science ®Google Scholar
• Falco MD, D'Andrea M, Fedele D, Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer. Br J Radiol 2011;84(1005):819–825.
   PubMed Web of Science ®Google Scholar
• Carosi A, Ingrosso G, Ponti E, Dosimetric effect of Elekta Beam Modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Med Dosim 2014 (in press).
   PubMed Web of Science ®Google Scholar
• Fiorino C, Valdagni R, Rancati T, Dose-volume effects for normal tissues in external radiotherapy: Pelvis. Radiother Oncol 2009;93(2):153–167.
   PubMed Web of Science ®Google Scholar
• Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 1999;43(3):475–479.
   PubMed Web of Science ®Google Scholar
• Vargas C, Martinez A, Kestin LL, Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2005;62(5):1297–1308.
   PubMed Web of Science ®Google Scholar
• Peeters ST, Heemsbergen WD, van Putten WL, Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005;61(4):1019–1034.
   PubMed Web of Science ®Google Scholar
• Schultheiss TE, Lee WR, Hunt MA, Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997;37(1):3–11.
   PubMed Web of Science ®Google Scholar
• Liu M, Pickles T, Berthelet E, Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. Radiother Oncol 2005;74(2):197–201.
   PubMed Web of Science ®Google Scholar
• Sandhu AS, Zelefsky MJ, Lee HJ, Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys 2000;48(3):643–647.
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, van Putten WL, Heemsbergen WD, Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;72(4):980–988.
   PubMed Web of Science ®Google Scholar
• Gill S, Thomas J, Fox C, Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol 2011;28(6):145.
   Google Scholar
• Takeda K, Takai Y, Narazaki K, Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan. Radiat Oncol 2012;6(7): 105.
   Google Scholar
• Sveistrup J, Af Rosenschöld PM, Deasy JO, Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Radiat Oncol 2014;49(1):44.
   Google Scholar